Clinical Trial Update: G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update comparing G-CSF+DAC+BUCY versus G-CSF+DAC+BF conditioning regimens for high-risk myelodysplastic syndrome patients undergoing allogeneic h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allogeneic Hematopoietic Stem Cell Transplantation
• Myelodysplastic Syndrome

Drugs mentioned

• G-CSF+DAC+BF
• G-CSF+DAC+BUCY

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN